- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Sobngwi Eugene
Total 1754 results
-
Real Fundación Victoria EugeniaUniversidad de Murcia; Medtep Inc.Unknown
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
Indiana University School of MedicineCelgene CorporationTerminatedHepatocellular CarcinomaUnited States
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; Celgene CorporationCompleted
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Celgene CorporationCompletedMyelodysplasiaUnited States
-
Taysha Gene Therapies, Inc.Withdrawn
-
Gene PreDiTBlueclinical, Ltd.Terminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
Grupo Español Multidisciplinar de MelanomaMirati Therapeutics Inc.; BeiGeneActive, not recruiting
-
Psoriasis Treatment Center of Central New JerseyCelgene CorporationCompleted
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
Alliance Foundation Trials, LLC.Bristol-Myers Squibb; Celgene CorporationTerminatedNonsmall Cell Lung Cancer | Non Small Cell Lung Cancer Recurrent | Non-Small Cell Carcinoma of Lung, TNM Stage 4 | Non-Small-Cell Lung Cancer MetastaticUnited States
-
IRCCS Eugenio MedeaUniversity of Pisa; University of MessinaCompleted
-
Weiyun AiCelgene CorporationCompletedLymphoma | T-Cell Lymphoma | Cutaneous LymphomaUnited States
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedMultiple MyelomaUnited States
-
Catholic University of the Sacred HeartIRCCS Eugenio MedeaUnknown
-
University of California, DavisEli Lilly and Company; CelgeneTerminatedBreast Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Thomas KippsCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
Washington University School of MedicineWugen, Inc.WithdrawnMyelodysplastic Syndromes | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid Leukemia
-
Gustave Roussy, Cancer Campus, Grand ParisBeiGene; C2i GenomicsNot yet recruitingSoft Tissue Sarcoma | Cancer | Lung Cancer | Pancreas Cancer | Colo-rectal CancerFrance
-
Weill Medical College of Cornell UniversityGenentech, Inc.; BeiGeneRecruitingLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
The First Affiliated Hospital of Xinxiang Medical...BeiGeneNot yet recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteBeiGeneRecruitingProstate Cancer | Stage IV Prostate CancerUnited States
-
Queen Mary University of LondonMedical Research Council; CelgeneNot yet recruiting
-
Sun Yat-sen UniversityHangzhou Repugene Technology Co., Ltd.RecruitingNon-Small Cell Lung CancerChina
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Wake Forest University Health SciencesCelgene; Amgen; Janssen, LPActive, not recruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; CelgeneActive, not recruitingMetastatic Melanoma | Melanoma and Other Malignant Neoplasms of SkinUnited States
-
Investigación en Hemofilia y FisioterapiaReal Fundación Victoria EugeniaCompleted
-
University of PadovaULSS 6 Euganea; Nastrificio Victor S.p.A.CompletedAutism Spectrum DisorderItaly
-
University of WashingtonNational Cancer Institute (NCI); Celgene CorporationCompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Institut fuer FrauengesundheitMerck Sharp & Dohme LLC; Celgene CorporationCompletedMalignant Neoplasm of BreastGermany
-
University of Texas Southwestern Medical CenterGenentech, Inc.; CelgeneCompletedLung Cancer | Metastatic CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Jean-Luc Van LaethemCelgene CorporationCompletedPancreatic Adenocarcinoma Resectable | Pancreatic Adenocarcinoma Metastatic | Pancreatic Adenocarcinoma Locally AdvancedBelgium
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
IRCCS Eugenio MedeaSol et Salus Hospital, Rimini, ItalyCompletedCerebral Palsy | Acquired Brain InjuryItaly
-
University Hospital, LimogesMinistry of Health, France; Celgene CorporationCompleted
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
University of California, San DiegoGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Icahn School of Medicine at Mount SinaiCelgene CorporationTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMyelomaUnited States
-
M.D. Anderson Cancer CenterBayer; Celgene; Onyx Therapeutics, Inc.Completed
-
Accelerated Community Oncology Research NetworkGenentech, Inc.; Celgene CorporationCompletedEpithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States
-
University of LeipzigMundipharma Pte Ltd.; Celgene Corporation; AmgenUnknown